BBIO - BridgeBio Pharma, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$105.15
DETAILS
HIGH:
$157.00
LOW:
$83.00
MEDIAN:
$100.00
CONSENSUS:
$105.15
UPSIDE:
52.13%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 94.4% |
| EBIT Margin | -135.8% |
| EBITDA Margin | -134.0% |
| Operating Margin | -113.3% |
| Pretax Margin | -146.4% |
| Cont. Ops Margin | -146.5% |
| Net Margin | -145.3% |
| Bottom Line Margin | -145.3% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 2.62 |
| Quick Ratio | 2.52 |
| Solvency Ratio | -0.239 |
| Cash Ratio | 1.98 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-20.69
Peers avg: 40.7
|
| PEG Ratio | -0.65 |
| Forward PEG | -0.65 |
| Price/Book | -7.27 |
| Price/Sales | 30.05 |
| Price/FCF | -33.75 |
| Price/Op Cash Flow | -33.83 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 2.9152 |
| Debt/Equity | -1.3140 |
| Debt/Capital | 4.1842 |
| Long-Term Debt/Capital | 4.2914 |
| Financial Leverage | -0.45 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.97 |
| Operating Cash Flow Ratio | -1.548 |
| Operating Cash Flow/Sales | -88.8% |
| Free Cash Flow/Operating Cash Flow | 100.2% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -9.55 |
| Interest Coverage | -10.7167 |
| Short-Term Operating Cash Flow Coverage | -25.61 |
| Operating Cash Flow Coverage | -0.16 |
| Capital Expenditure Coverage | -406.48 |
| Dividend + Capital Expenditure Coverage | -406.48 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 2.55 |
| EPS | -3.698 |
| Debt/Share | 14.1039 |
| Cash/Share | 2.98 |
| Book Value/Share | -10.53 |
| Tangible BV/Share | -10.67 |
| Equity/Share | -10.53 |
| Operating Cash Flow/Share | -2.261 |
| Capital Expenditure/Share | 0.006 |
| FCF/Share | -2.266 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.992 |
| Earnings Before Tax/EBIT | 1.292 |
| Price/Fair Value | -7.27 |
| Debt/Market Cap | 0.1806 |
| Effective Tax Rate | -0.1% |
| Enterprise Value Multiple | -25.63 |